z-logo
open-access-imgOpen Access
A Phase 1b clinical trial of LDE225 (Sonidegib) in combination with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFIRINOX) in previously untreated locally advanced or metastatic pancreatic adenocarcinoma
Author(s) -
Jeffrey W. Clark,
Nora Horick,
Jill N. Allen,
Lawrence S. Blaszkowsky,
Janet E. Murphy,
Charles S. Fuchs,
Brian M. Wolpin,
Robert J. Mayer,
Jason E. Farris,
Jennifer A. Chan,
Kimmie Ng,
Nadine J. McCleary,
Thomas A. Abrams,
David P. Ryan,
Eunice L. Kwak,
Theodore S. Hong
Publication year - 2021
Publication title -
annals of pancreatic cancer
Language(s) - English
Resource type - Journals
ISSN - 2616-2741
DOI - 10.21037/apc-20-41
Subject(s) - folfirinox , oxaliplatin , irinotecan , medicine , fluorouracil , oncology , gemcitabine , adenocarcinoma , metastatic adenocarcinoma , chemotherapy , colorectal cancer , cancer

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here